Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30day mortality in patients with ST-elevated myocardial infarction

This publication has 23 references indexed in Scilit:

• Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
  New England Journal of Medicine, 2014
• Effect of Addition of Clopidogrel to Aspirin on Mortality
  Stroke, 2012
• Forest Plot Viewer
  Epidemiology, 2011
• Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
  Circulation, 2010
• Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2009
• Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2007
• Incremental Effect of Clopidogrel on Important??Outcomes in Patients with Cardiovascular Disease
  American Journal of Cardiovascular Drugs, 2007
• Comment: Mortality Benefit of No-Load Clopidogrel in COMMIT: Not a Surprise
  Journal of Cardiovascular Pharmacology and Therapeutics, 2006
• Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
  The Lancet, 2005
• Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting
  JAMA, 2000